Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Explore various ways to make money online today. These opportunities can help you earn from the comfort of your home.
20,182 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
A strong pharma dividend stock could be a powerful component of a retirement plan. Learn how to choose, invest, and c...
'scream 7' opened with a $64.1 million domestic debut, the year’s best start and a clear sign that millennial nostalg...
Asana's 2026 earnings outlook blends strong ARR growth with improving efficiency. This guide breaks down the key numb...
A gold miner’s stock has doubled in 12 months and just raised its dividend by 60%. This deep-dive explains what drive...
Duquesne Family Office reveals a sizable XLF position in its Q4 2025 filings, marking one of the boldest bets on fina...
Investors are eyeing a smarter play bitcoin recovery that avoids direct bitcoin ownership while still tapping into th...
Viemed's 2025 earnings outlook hinges on growing demand for home respiratory care, reimbursement dynamics, and cost c...
IAMGOLD has rocketed higher over the past year, with a 273% gain in 12 months. The driving force is not just gold's r...
A new AI risk assessment shows programmers face high displacement risk, upending traditional SaaS models and pressuri...
Zscaler is steering its platform toward AI-driven security, aiming to reshape enterprise defense and investor returns...
Geopolitical tensions push oil higher, sparking a potential wave of higher gas prices and new bets in energy markets....